McDermott +Bull has successfully placed Enrico Brambilla as Vice President, Product Research and Development at Eyenovia. Reporting to the COO, Enrico will lead a team of high-performing engineers and be accountable for the design, development, and qualification of...
McDermott + Bull Interim Leaders Senior Managing Director James Hickey and Vice President of Talent Acquisition Tamra Solis have successfully placed an interim Vice President of Human Resources for a privately held biotech company in Southern California. The company...
McDermott + Bull has successfully placed Ivan Velazquez and John Harrington as Vice President of Operations for private equity-backed Specialty Dental Brands, a Leon Capital Group portfolio company. Both Ivan and John will oversee the day-to-day operations of a...
McDermott + Bull has successfully placed Chris Robillard as the Chief Business Officer at Crinetics Pharmaceuticals. Chris will develop, lead, and execute on the company’s business development strategy. He will build global pharmaceutical alliances to maximize the...
McDermott + Bull Interim Leaders Senior Managing Director James Hickey and Vice President of Talent Acquisition Tamra Solis have successfully placed an interim Chief Financial Officer (CFO) for an East Coast healthcare services company that is based in California. ...
LIFE SCIENCES + HEALTHCARE OUTLOOK IN 2022 When the J.P. Morgan Healthcare Conference took place last January, I skipped it, optimistically thinking that things would be different and safer the following year. Shortly before this year’s conference, it was announced...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy policy
